10^th Global Ophthalmology Meeting

Prof. Neuhann has been using the Excimer laser technique from a very early stage, and has been performing laser surgeries since the late ’80s. In 1999, Dr. Neuhann was honored as a “Pioneer of Refractive Surgery” in the United States. In 2005, he was additionally voted one of “TOP 50 Opinion Leaders” for Outstanding Contribution and Leadership in the Fields of Cataract and Refractive Surgery. Prof. Neuhann has been president for VSDAR (Organization of German Specialty Clinics for Laser Eye and Refractive Surgery) since 2006. Prof. Dr. Thomas Friedrich Wilhelm Neuhann works at the eye clinic in Munich as well as in the joint ophthalmological practice of Prof. Neuhann and colleagues and as an attending physician in the eye department of the Red Cross Clinic in Munich. He also runs the non-profit cornea bank he founded in Munich, which arranges 1,500 to 2,000 corneas for transplantation every year. He himself performs around 300 corneal transplants every year.

Surgical innovations in cataract surgery

In 2004 Hr. Dr. Bauer was one of the first eye surgeons to introduce the Femto LASIK Technology. Due to his extensive experience, he is a consultant of the Commission for Refractive Surgery in Germany for the training of ophthalmologists in refractive surgery. Dr. med. Bauer is one of the first refractive surgeons to be certified after LASIK TÜV. He is also a speaker at conferences of the German Ophthalmic Surgeons and the European Society of Cataract and Refractive Surgery. The process of collagen cross-linking in the treatment of keratoconus was performed and established by him in 2006 – the first time in Munich.

Ophthalmology

Eric D. Donnenfeld, MD, was named Newsweek’s best ophthalmologist in the country in 2023, 2022 and 2021 on Newsweek’s list of top eye doctors in the United States. He received a near perfect score for quality of care, continuity of care, and the quality of the technology used in his practice. Dr. Donnenfeld was also named on Ophthalmology Management’s 25 Leaders in Innovation, and on The Ophthalmologist’s Power List in 2018 and 2022.

Surgical innovations in cataract surgery

Dr. Park is a board certified ophthalmologist by Korean Ophthalmology Society. He is the Chairman of Department of Ophthalmology, Dongguk University Hospital, South Korea. He graduated Seoul National University, College of Medicine and completed PhD at Samsung Medical Center, Sungkyunkwan University, Seoul. He investigated adenovirus mediated intraocular gene delivery during his post-doc period at Wilmer Eye Institute, Johns Hopkins University, US. His area of expertise is cataract surgery, corneal surgery and refractive surgery. His clinical research interest includes optimizing refractive outcome after multifocal intraocular lens, corneal crosslinking, novel pterygium surgery, and acanthamoeba keratitis.

Ocular drug delivery system, ophthalmic use of nanoparticles, nitric oxide application for ocular surface diseases, and bioengineering of corneal endothelial cells.

Andrzej Grzybowski, M.D., Ph.D., MBA, is a Professor of Ophthalmology and Chair of Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland; Head of Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland. He is active in international scientific societies including Euretina (Co-opted Board member 2016-2018), Retina Society, AAO, EVER, ESCRS, and ISRS, ISBCS, International Council of Ophthalmology, and Cogan Society. He became lifelong member (chair LIV) of the European Academy of Ophthalmology and is a member of Ophthalmic Education Consortium (OEC) advisory committee of Ophthalmology Foundation. He has been active contributor to major ophthalmic conferences worldwide, including AAO, APAO, WCO, CCOS, Euretina, ESCRS, EVER, ISOPT, etc. As the only Polish ophthalmologist he was included in TOP 2% ranking of world-best scientists prepared by Stanford University for 2019 and 2020. Expertscape worldwide ranking: No 1 in cataract field and No 1 in cataract extraction field. In 2021, he received ISRS (International Society for Refractive Surgery) Founders’ Award, and published a book Artificial Intelligence in Ophthalmology (Springer). In 2022 he was awarded OFFICERS' CROSS OF THE ORDER OF POLONIA RESTITUTA for outstanding achievements in research and teaching, and support for international scientific cooperation by President of Poland.

Ophthalmology

Dr. Javier Zarranz-Ventura obtained his medical degree at Universidad de Navarra, specialist training in ophthalmology at Clínica Universidad de Navarra, and a PhD in medicine at Universidad de Navarra, awarded cum laude with European mention. He underwent a fellowship in medical retina and uveitis at Moorfields Eye Hospital in London and two fellowships in vitreoretinal surgery in Gloucestershire and Bristol (2011-2014). He has been working as a vitreoretinal surgeon at the Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic de Barcelona, and Hospital Universitari Sagrat Cor in Barcelona since May 2014. His main clinical and research interests are age-related macular degeneration (AMD), diabetic eye disease, and vitreoretinal surgery, as well as retinal imaging techniques, particularly OCT and OCT-A, and Artificial Intelligence. He is member of numerous scientific societies such as EURETINA, BEAVRS, ARVO and the Spanish Society of Retina and Vitreous (SERV). Dr. Zarranz-Ventura has authored >250 scientific communications, >75 scientific papers, >35 book chapters, and 3 books, and has given >160 invited lectures. He has a H-index of 20, an i10-index of 37, and has >1600 citations.

Age-related macular degeneration (AMD), diabetic eye disease, and vitreoretinal surgery, as well as retinal imaging techniques, particularly OCT and OCT-A, and Artificial Intelligence.

Dr Papageorgiou is a consultant ophthalmic surgeon, specialized in pediatric ophthalmology, strabismus and neuroophthalmology at the University Hospital of Larissa Greece. She graduated from the Medical School of the Aristoteles University Thessaloniki Greece, and subsequently completed a PhD in Neuroscience-Neuroophthalmology at the University of Tuebingen, Germany, funded by a Marie-Curie EU-Programme. Dr Papageorgiou has completed her specialist training in Ophthalmology at the Centre for Ophthalmology, University of Tuebingen, and then completed a fellowship in Pediatric Ophthalmology and Strabismus at the University of Leicester, UK. Her practice focuses on the management of primary, secondary and tertiary care of patients with strabismus and ocular motor disorders, as well as general paediatric ophthalmology. She is active in resident training and is also involved in student education. Her research focuses on amblyopia management, pediatric ocular imaging, driving with visual field deficits and ocular manifestations of neurological disease. In 2014 she became an Associate Editor, and in 2020 a Senior Editorial Board Member for BMC Ophthalmology.

Pediatric ophthalmology, strabismus and neuroophthalmology

Michele Figus, M.D., Ph.D, works as Associate Professor of Ophthalmology and Chairman of the Residency Training Program since 2018 at the University of Pisa, Italy. He is currently Head of Ophthalmology at Azienda Ospedaliero Universitaria Pisana, in Pisa. Fellow of the European Board of Ophthalmology he has been elected as National Expert in Diagnosis for the Italian Ophthalmology Society for ten years and Board member in the Health Art Academy in Italy and in ophthalmic societies. He leaded as Principal Investigator many clinical trials and published more than 140 papers in JCR Impact Factor indexed Journals.

Glaucoma, focused on Glaucoma surgery

Penny Asbell, MD, FACS, MBA, FARVO, holds the Barrett G. Haik Endowed Chair, Department of Ophthalmology, Hamilton Eye Institute and is Professor of Ophthalmology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC) in Memphis TN. Dr. Asbell has received numerous awards, including the Phillips Thygeson Lecturer honor from the University of California-San Francisco, the Meibom-Moore Lecturer of Honor award (Dusseldorf), and the Secretariat Award from the American Academy of Ophthalmology and has been named Fellow of ARVO. Her research areas of interest include cornea, anterior segment surgery, ocular biomarkers, refractive surgery and antibiotic resistance in eye infections. She has published over 200 peer reviewed articles. Dr. Asbell has been the Principal Investigator for over 100 clinical trials, including HEDS study on treating ocular herpes simplex disease, PERK study that set the standard for evaluations of refractive surgery procedures, and DREAM on the use of Omega 3 for dry eye disease.

Cornea, anterior segment surgery, ocular biomarkers, refractive surgery and antibiotic resistance in eye infections